BITMIS CORP. (BIMT) Financial Statements (2023 and earlier)

Company Profile

Business Address UNIT NO. 5784
BANGKOK, 10500
State of Incorp. NV
Fiscal Year End June 30
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2023
MRQ
6/30/2022
6/30/2019
6/30/2018
6/30/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 11938
Cash and cash equivalents 11938
Receivables    
Inventory, net of allowances, customer advances and progress billings    
Inventory    
Prepaid expense 1  
Other undisclosed current assets    
Total current assets: 21938
Noncurrent Assets
Property, plant and equipment 033
Other undisclosed noncurrent assets  219 
Total noncurrent assets: 3223
Other undisclosed assets  (4)(39) 
TOTAL ASSETS: 0341
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities260 
Employee-related liabilities 4  
Accounts payable210 
Accrued liabilities    
Debt  4 
Due to related parties 7   
Other undisclosed current liabilities 0  
Total current liabilities:964 
Noncurrent Liabilities
Liabilities, other than long-term debt    14
Deferred revenue and credits 9
Accounts payable and accrued liabilities    3
Due to related parties    2
Other undisclosed noncurrent liabilities  (3)19 
Total noncurrent liabilities:  (3)1914
Total liabilities:932214
Equity
Equity, attributable to parent, including:(9)(3)1927
Preferred stock    
Common stock6  6
Common stock, value, subscriptions  5,000  
Additional paid in capital31242424
Accumulated other comprehensive income    
Accumulated deficit(47)(33)(11)(3)
Other undisclosed equity, attributable to parent (4,994)6 
Other undisclosed equity  (3)(22) 
Total equity:(9)(6)(4)27
TOTAL LIABILITIES AND EQUITY: (3)1941

Income Statement (P&L) ($ in thousands)

3/31/2023
TTM
6/30/2022
6/30/2019
6/30/2018
6/30/2017
Revenues  1811
Revenue, net 11
Cost of revenue
(Other undisclosed Cost of revenue)
    
Other undisclosed gross profit   (3) 
Gross profit:  1511
Operating expenses(7)(22)8(13)
Other undisclosed operating loss   (31) 
Operating loss:(7)(22)(8)(2)
Nonoperating income
(Other Nonoperating income)
    
Loss from continuing operations:(7)(22)(8)(2)
Loss before gain (loss) on sale of properties:(7)(22)(8)(2)
Net loss available to common stockholders, diluted:(7)(22)(8)(2)

Comprehensive Income ($ in thousands)

3/31/2023
TTM
6/30/2022
6/30/2019
6/30/2018
6/30/2017
Net loss:(7)(22)(8)(2)
Comprehensive loss:(7)(22)(8)(2)
Other undisclosed comprehensive loss, net of tax, attributable to parent    
Comprehensive loss, net of tax, attributable to parent:(7)(22)(8)(2)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: